← Leaderboards
Jia-Qiang He
Cellular Dynamics International, Inc.
$1,552,620
Attributed
$1,552,620
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $483K · FY2007–18$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,552,620 · 5
By mechanism
P20$569,824 · 3
R43$499,796 · 1
R15$483,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSourceHeartResearch PersonnelIn VitroCardiacMyocardiumStem CellsResearch StudyTp53 GeneNon-DiabeticHyperglycemiaResourcesGrowthIn VivoDiabetic CardiomyopathyArchitectureFundingCostDiabetes MellitusCell DeathDiabeticGrantUnited States National Institutes Of Health
Grant awards (6)
Meis1 Negatively Regulates Blood Flow in Hindlimb Ischemia$483,000
R15 · FY2018 · HL · contact PI
STEM CELLS AND DIABETIC CARDIOMYOPATHY PROJ 2 2009$191,692
P20 · FY2011 · RR · contact PI
STEM CELLS AND DIABETIC CARDIOMYOPATHY PROJ 2 2009$193,628
P20 · FY2010 · RR · contact PI
STEM CELLS AND DIABETIC CARDIOMYOPATHY$184,504
P20 · FY2009 · RR · contact PI
Human Embryonic Stem Cell-Derived Cardiomyocytes for In Vitro Drug Screening$249,898
R43 · FY2008 · HL · contact PI
Human Embryonic Stem Cell-Derived Cardiomyocytes for In Vitro Drug Screening$249,898
R43 · FY2007 · HL · contact PI